Patent · US Active

PEG-modified arginine/lysine oxidoreductase

US8759060B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

Thomas Rudel · DE

Inventors

Christian Hofmann · Erlangen, DE
Michael Lindemann · Schopfheim, DE

Key dates

Filing date	Sep 9, 2013
Grant date	Jun 24, 2014
Priority date	—
Expiry date	Sep 9, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N9/96
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to an arginine/lysine oxidoreductase modified with polyethylene glycol, a production method thereof, and methods of treating disorders responsive to a modification of amino acid levels reactive oxygen species and/or ammonium.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.